ERBB2 and breast carcinoma: In the analysis of HER2 status (Figure 4A), it was found that the expression level of CDK1 in HER2-negative patients was higher than that in HER2-positive patients, suggesting that CDK1 may play a more important role in HER2-negative breast cancer.